‘It really is upwards from here,’ Pacific Edge CEO

‘It really is upwards from here,’ Pacific Edge CEO
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Rebecca Howard
Pacific Edge chief executive Peter Meintjes is optimistic that the company can capitalise on its “first-mover advantage” despite its Cxbladder tests losing coverage in the US.Pacific Edge’s suite of Cxbladder tests detects bladder cancer by analysing a urine sample for specific genetic markers. The test is non-invasive, requiring only a small urine sample. The results are combined with clinical data to provide a risk score.The change in disposition toward non-invasive tests that use biomarkers has been “incredibly n...

More Markets

Airports v airlines and the regional monopoly conundrum
Policy Analysis

Airports v airlines and the regional monopoly conundrum

Why is airport regulation being reviewed when all the fuss is about airfares? 

Auckland Airport dominates volumes; NZX dips 0.61%
Markets Market Close

Auckland Airport dominates volumes; NZX dips 0.61%

The S&P/ASX 200 has recovered from the US's so-called "Liberation Day".

Gregor Thompson 29 Apr 2025
Fonterra to close its Hamilton canning and packaging facility
Primary Sector

Fonterra to close its Hamilton canning and packaging facility

It will close at the end of July, affecting 120 jobs.

Riley Kennedy 29 Apr 2025
Pacific Edge upbeat about latest move for new test
Markets

Pacific Edge upbeat about latest move for new test

The median price for Cxbladder Triage Plus is US$1,018.44.

Rebecca Howard 29 Apr 2025